TW202106336A - 用於促進ｇｌｐ－１分泌之組成物 - Google Patents

用於促進ｇｌｐ－１分泌之組成物 Download PDF

Info

Publication number
TW202106336A
TW202106336A TW109113759A TW109113759A TW202106336A TW 202106336 A TW202106336 A TW 202106336A TW 109113759 A TW109113759 A TW 109113759A TW 109113759 A TW109113759 A TW 109113759A TW 202106336 A TW202106336 A TW 202106336A
Authority
TW
Taiwan
Prior art keywords
glp
sample
secretion
composition
reba
Prior art date
Application number
TW109113759A
Other languages
English (en)
Chinese (zh)
Inventor
浦井聡一郎
長尾浩二
横尾芳明
Original Assignee
日商三得利控股股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商三得利控股股份有限公司 filed Critical 日商三得利控股股份有限公司
Publication of TW202106336A publication Critical patent/TW202106336A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
TW109113759A 2019-04-26 2020-04-24 用於促進ｇｌｐ－１分泌之組成物 TW202106336A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019086871 2019-04-26
JP2019-086871 2019-04-26

Publications (1)

Publication Number Publication Date
TW202106336A true TW202106336A (zh) 2021-02-16

Family

ID=72941928

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109113759A TW202106336A (zh) 2019-04-26 2020-04-24 用於促進ｇｌｐ－１分泌之組成物

Country Status (3)

Country Link
JP (1) JPWO2020218381A1 (fr)
TW (1) TW202106336A (fr)
WO (1) WO2020218381A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4317452A1 (fr) * 2021-03-22 2024-02-07 The Nisshin Oillio Group, Ltd. Procédé de criblage de l'agent régulateur de la sécrétion de glp-1, agent régulateur de la sécrétion de glp-1, composition pour prévenir ou atténuer le diabète, l'obésité, l'hyperglycémie postprandiale, les maladies neurodégénératives, l'hypoglycémie, l'adiposité ou la nesidioblastose, procédé pour favoriser la sécrétion de glp-1 dans des cellules exprimant gpr84, procédé pour produire une composition favorisant la sécrétion de glp-1, utilisation d'un agoniste de gpr84 pour produire un agent thérapeutique pour une maladie, agent favorisant la sécrétion de glp-1, et composition pour ingestion orale

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0710338B2 (ja) * 1987-12-28 1995-02-08 有限会社野々川商事 多価アルコール中油型乳化組成物及び水中油型乳化組成物
JP2011046668A (ja) * 2009-08-28 2011-03-10 Nof Corp Ｇｌｐ−１及びインスリンの分泌持続調整剤
JP2015047080A (ja) * 2013-08-30 2015-03-16 株式会社ファンケル 乳化組成物
US10772346B2 (en) * 2014-02-21 2020-09-15 James and Carol May Family, LLLP Compositions and methods for the solubilization of stevia glycosides
WO2017018404A1 (fr) * 2015-07-27 2017-02-02 サントリーホールディングス株式会社 Composition contenant un dipeptide cyclique et un édulcorant
EP3664626B1 (fr) * 2017-08-08 2023-09-06 eBio Nutritional Sciences LLC Composition d'édulcorant et ses procédés de production

Also Published As

Publication number Publication date
WO2020218381A1 (fr) 2020-10-29
JPWO2020218381A1 (fr) 2020-10-29

Similar Documents

Publication Publication Date Title
TWI519243B (zh) 濃厚流質食品
JP5876205B2 (ja) Ｄ−ソルボースからなる甘味料におけるｄ−ソルボースの甘味の不足や、甘味の持続を改良する方法
JP2011126852A (ja) 貧血改善組成物及び飲食品
JP2009173634A (ja) ポリ−γ−グルタミン酸を含有する脂質吸収阻害剤
JP2012136471A (ja) 酸性液状栄養組成物
WO2004105739A1 (fr) Compositions, aliments et boissons contenant un derive d'acide gras superieur
JP2017514521A (ja) 電解質補給物をもたらすための食品、システム、方法、及びキット
JP2009286703A (ja) Ｄ−タガトースを有効成分とする体脂肪蓄積改善剤およびメタボリックシンドローム改善剤
JP2024026804A (ja) 疲労感、意欲低下または眠気の改善剤
KR20060119706A (ko) 생활 습관병 예방ㆍ개선용의 유지 가공 조성물
TWI796560B (zh) 用於促進ｇｌｐ－１分泌之組成物
TW202106336A (zh) 用於促進ｇｌｐ－１分泌之組成物
TWI790434B (zh) 用於促進ｇｌｐ－１分泌之組成物
TW202106309A (zh) Ｇｌｐ－１分泌促進劑
JP4915959B2 (ja) 砂糖様味質をもつ新規甘味料、その製造法および用途
TW202106308A (zh) Ｇｌｐ－１分泌促進劑
JP4997514B2 (ja) 血圧上昇抑制剤
WO2012150675A1 (fr) Composition contenant du panaxadiol
JP5943516B2 (ja) Ｄ−ソルボースを有効成分とする生体機能改善用甘味料
JP2023175314A (ja) 便通改善用組成物及び機能性表示食品
JP2020094021A (ja) レスベラトロール誘導体の新規製造方法および新規用途
JP2005325086A (ja) 睡眠障害予防及び／又は治療剤、機能性食品又は化粧料
IL261544A (en) Lipid preparations and their uses